BN Business News
Add your company to Business Communicator →

Finanse publiczne · 26/09/2014

Branded Prescription Drug Fee; Correction

The Internal Revenue Service (IRS) has released a correction to a notice of proposed rulemaking regarding the branded prescription drug fee, which was initially published on July 28, 2014. The correction addresses temporary regulations related to the fee, specifically modifying the definition of controlled group.

Source: Federal Register — Department of the TreasuryOpen original release →